Spain Continuous Glucose Monitoring Market - Forecasts from 2025 to 2030

Description

Spain's continuous glucose monitoring market to surpass US$114.025 million by 2030, growing at a 10.39% CAGR from US$69.552 million in 2025.

The Spanish CGM market is booming due to the strong prevalence of diabetes and a huge focus on glycemic control. Technological advancements, like smaller sensors and longer wear times, are also improving patient experience and driving market expansion. For instance, in February 2024, Dexcom, Inc. launched its new CGM system, Dexcom ONE+, for people with diabetes worldwide. In some countries, Dexcom ONE+ supersedes the previous generation Dexcom ONE sensor.

Market Trends:

Increasing diabetes prevalence driving CGM adoption in Spain: The growing number of diabetes cases in Spain is fueling the demand for effective diabetes management solutions. Continuous Glucose Monitoring (CGM) devices provide critical insights into blood glucose levels, helping patients and healthcare professionals make informed decisions about diet, physical activity, and medication.
Significant growth in the male CGM market in Spain: The CGM market for males in Spain is expanding rapidly, driven by factors such as the high prevalence of diabetes, particularly type 2. CGM devices play a crucial role in managing blood sugar levels by offering real-time data, benefiting both patients and healthcare providers.
Rising demand among adults aged 20 and older: The CGM market for adults aged 20 and above in Spain is experiencing substantial growth, primarily due to the increasing prevalence of diabetes, especially type 2, within this age group. CGM devices are essential for effective blood sugar management, reducing the risk of diabetes-related complications. By 2030, it is estimated that 11.8% of Spaniards aged 20 and older will have diabetes, further driving the demand for CGM technology.

Some of the major players covered in this report include Dexcom, Inc., Abbott Laboratories, Medtronic, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, Inc., DiaMonTech AG, among others.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Spain continuous glucose monitoring Market is analyzed into the following segments:

By Type

Real-Time CGM
Intermittently CGM

By Gender

Male
Female

By Age

Greater than 20
Less than 20

By Application

Diabetes Patients
Critical Patients

By End-User

Hospitals
Diagnostic Center and Clinics
Home Care

Product Code: KSI061614943

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. The Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. SPAIN CONTINUOUS GLUCOSE MONITORING MARKET BY TYPE

5.1. Introduction
5.2. Real-Time CGM
5.3. Intermittently CGM

6. SPAIN CONTINUOUS GLUCOSE MONITORING MARKET BY GENDER

6.1. Introduction
6.2. Male
6.3. Female

7. SPAIN CONTINUOUS GLUCOSE MONITORING MARKET BY AGE

7.1. Introduction
7.2. Greater than 20
7.3. Less than 20

8. SPAIN CONTINUOUS GLUCOSE MONITORING MARKET BY APPLICATION

8.1. Introduction
8.2. Diabetes Patients
8.3. Critical Patients

9. SPAIN CONTINUOUS GLUCOSE MONITORING MARKET BY END-USER

9.1. Introduction
9.2. Hospitals
9.3. Diagnostic Center and Clinics
9.4. Home Care

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Dexcom, Inc.
11.2. Abbott Laboratories
11.3. Medtronic
11.4. F. Hoffmann-La Roche Ltd.
11.5. Ascensia Diabetes Care
11.6. Insulet Corporation
11.7. Tandem Diabetes Care, Inc.
11.8. DiaMonTech AG
11.9. A. Menarini Diagnostics
11.10. Insulcloud S.L.
11.11. YPSOMED
11.12. Diabeloop SA
11.13. MicroTech Medical, Inc